# Hydroxychloroquine in Patients With Stage III or Stage IV Melanoma That Can Be Removed by Surgery

> **NCT00962845** · EARLY_PHASE1 · COMPLETED · sponsor: **Rutgers, The State University of New Jersey** · enrollment: 20 (actual)

## Conditions studied

- Melanoma (Skin)

## Interventions

- **DRUG:** hydroxychloroquine

## Key facts

- **NCT ID:** NCT00962845
- **Lead sponsor:** Rutgers, The State University of New Jersey
- **Sponsor class:** OTHER
- **Phase:** EARLY_PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2010-09
- **Primary completion:** 2013-05-30
- **Final completion:** 2013-05-30
- **Target enrollment:** 20 (ACTUAL)
- **Last updated:** 2022-09-07

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00962845

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00962845, "Hydroxychloroquine in Patients With Stage III or Stage IV Melanoma That Can Be Removed by Surgery". Retrieved via AI Analytics 2026-07-15 from https://api.ai-analytics.org/clinical/NCT00962845. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*